Member Info for Kaeren

I believe that is correct as I read that difficulty encountered with some dialysis patients trying to find a suitable vein.

Click on the name to see posting history was a very good tip to me as a newcomer ! Stops any rash decisions , all becomes clear .

Click on the name to see posting history was a very good tip to me as a newcomer !

So will this change who buys this share? Will the big boys arrive Monday ?

Climbed off the naughty stool, thank you all

Thank you VAN V for your endless work in getting the company name into the public domain. I shall raise a glass to you tonight!!

WOODALO, some great posts from you today. Thx

Can I have some of what you are on! ANTiGEN

Ghia I have no clue if approval will be required ,but if I was in charge of purchasing and both to market at same time , then I would forward order from existing trusted supplier. Background not science orientated. Have a nice weekend.

Hi, I read that as they are three weeks away from targeting CE approval which is very different to three weeks to market for GDR. In the interim the Gold standard test is Novacyt with huge news expected next week.. Room for both but Novacyt is lightyears ahead of all its competitors. The merry go round 0f share jumpin will conti0nue and many will make a fortune and many will lose more then they can afford.

Yes NCYT are the only covid player with sales to back up share price, I have just increased holding.
Totally confident.

Absolutely no idea but not comparable to a two week stint in your local ICU.

So so true

On Synairgen sorry!

Has the proactive write up been posted? I can't do it, too new ! I think we should just keep reposting it! An impressive read lifted from RNS.

There lol, on the vino mucho collapso

Interesting, what was expected and is required.
Having missed out on the first batch of Novacyt test kits and bought inaccurate ones, the govt then placed their initial order. Moving forward, do we think the govt will ensure they have access to as many Novacyt tests as required or do we think they will sit and wait to see if a competitor crosses the line and it is accurate. The former not the latter would be my firm bet. This applies equally to the WHO and governments globally. They know their will be an enquiry after this and will not make the same mistake twice. The next RNS will be the length of the yellow pages with orders .Test Test Test .

ODX Antibody good for data analysis of disease spread, nothing else as antibodies do not prevent one catching C a second time.

Over pumping AVCT , doing the recommend this mail if you think the share price will dadada, just like he did here with recommend post as an experiment to see dadada

Remdesivir
I read but do not know where, that in patients
classified as severe it had a very negative impact but in patients classified as critical it had a positive impact. Wouldn't want a junior administering it to me.